Whether you are a member or non-member, you will receive the same level of high-quality care
We sought to investigate the real-world impact of sodiumglucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in individuals with type 1 diabetes in relation to effect on blood glucose levels, adverse events and cardio-renal outcomes
Why Insurance Denies GLP-1 Medications Insurance denials stem from three primary factors: medication classification, cost-benefit analysis, and plan-specific restrictions
To receive telemedicine visits, you must participate in another program at the store, which means additional expenses
Book an appointment today or call (02) 9889 3344 to get advice for your situation
Your healthcare provider or a registered dietitian can provide personalized nutrition guidance during therapy